112 related articles for article (PubMed ID: 2428557)
1. Effect of ganglionic blockade on endogenous circulating pancreatic polypeptide, vasoactive intestinal polypeptide, substance P, neurotensin and noradrenaline in healthy controls and long-term insulin-dependent diabetic patients.
Kastrup J; Henriksen JH; Pedersen JH; Fahrenkrug J; Schaffalitzky de Muckadell OB; Schwartz T; Parving HH; Christensen NJ
Clin Sci (Lond); 1986 Oct; 71(4):411-9. PubMed ID: 2428557
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a pancreatic tumor containing vasoactive intestinal peptide, neurotensin, and pancreatic polypeptide.
Shulkes A; Boden R; Cook I; Gallagher N; Furness JB
J Clin Endocrinol Metab; 1984 Jan; 58(1):41-8. PubMed ID: 6315763
[TBL] [Abstract][Full Text] [Related]
3. [Association of autonomic neuropathies and gastrointestinal peptides in non-insulin dependent diabetics].
Kostić N; Novaković R; Stajić S; Ratković M
Med Pregl; 1994; 47(5-6):168-71. PubMed ID: 7739457
[TBL] [Abstract][Full Text] [Related]
4. Effect of adrenal function on gastrointestinal peptide release in experimental cardiac arrest.
Wortsman J; Foley PJ; Malarkey WB; O'Dorisio TM; Tacker WA; Frank S
J Lab Clin Med; 1988 Jan; 111(1):104-9. PubMed ID: 2447214
[TBL] [Abstract][Full Text] [Related]
5. Serum peptide profiles in patients with carcinoid tumors.
Calhoun K; Toth-Fejel S; Cheek J; Pommier R
Am J Surg; 2003 Jul; 186(1):28-31. PubMed ID: 12842744
[TBL] [Abstract][Full Text] [Related]
6. Subnormal pancreatic polypeptide and epinephrine responses to insulin-induced hypoglycemia identify patients with insulin-dependent diabetes mellitus predisposed to develop overt autonomic neuropathy.
Kennedy FP; Go VL; Cryer PE; Bolli GB; Gerich JE
Ann Intern Med; 1988 Jan; 108(1):54-8. PubMed ID: 3276265
[TBL] [Abstract][Full Text] [Related]
7. Chronic pancreatitis and diabetes mellitus: plasma and gastroduodenal mucosal profiles of regulatory peptides (gastrin, motilin, secretin, cholecystokinin, gastric inhibitory polypeptide, somatostatin, VIP, substance P, pancreatic polypeptide, glucagon, enteroglucagon, neurotensin).
Domschke S; Bloom SR; Adrian TE; Lux G; Domschke W
Hepatogastroenterology; 1988 Oct; 35(5):229-37. PubMed ID: 2465985
[TBL] [Abstract][Full Text] [Related]
8. Unawareness of hypoglycaemia and inadequate hypoglycaemic counterregulation: no causal relation with diabetic autonomic neuropathy.
Ryder RE; Owens DR; Hayes TM; Ghatei MA; Bloom SR
BMJ; 1990 Oct; 301(6755):783-7. PubMed ID: 2224265
[TBL] [Abstract][Full Text] [Related]
9. Dopamine-beta-hydroxylase-, neurotensin-, substance P-, vasoactive intestinal polypeptide- and enkephalin-immunohistochemistry of paravertebral and prevertebral ganglia in the cat.
Heym C; Reinecke M; Weihe E; Forssmann WG
Cell Tissue Res; 1984; 235(2):411-8. PubMed ID: 6200232
[TBL] [Abstract][Full Text] [Related]
10. Plasma pancreatic polypeptide response to insulin-induced hypoglycemia as a marker for defective glucose counterregulation in insulin-dependent diabetes mellitus.
White NH; Gingerich RL; Levandoski LA; Cryer PE; Santiago JV
Diabetes; 1985 Sep; 34(9):870-5. PubMed ID: 2993084
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic polypeptide (PP) response to food in type I diabetics with and without diabetic autonomic neuropathy.
Hossdorf T; Wagner M; Hoppe HW
Hepatogastroenterology; 1988 Oct; 35(5):238-41. PubMed ID: 3229733
[TBL] [Abstract][Full Text] [Related]
12. Autonomic mediation of glucagon secretion during insulin-induced hypoglycemia in rhesus monkeys.
Havel PJ; Valverde C
Diabetes; 1996 Jul; 45(7):960-6. PubMed ID: 8666149
[TBL] [Abstract][Full Text] [Related]
13. Noradrenaline and isoproterenol kinetics in diabetic patients with and without autonomic neuropathy.
Dejgaard A; Hilsted J; Christensen NJ
Diabetologia; 1986 Nov; 29(11):773-7. PubMed ID: 3028892
[TBL] [Abstract][Full Text] [Related]
14. Peptidergic innervation of the mammalian sinus nodes: vasoactive intestinal polypeptide, neurotensin, substance P.
Weihe E; Reinecke M
Neurosci Lett; 1981 Nov; 26(3):283-8. PubMed ID: 6172750
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of vasoactive intestinal peptide and neurotensin secretion by pentagastrin in a patient with VIPoma syndrome.
Brunt LM; Mazoujian G; O'Dorisio TM; Wells SA
Surgery; 1994 Mar; 115(3):362-9. PubMed ID: 8128360
[TBL] [Abstract][Full Text] [Related]
16. The effect of pirenzepine on meal-stimulated gastrointestinal hormones.
El-Sabbagh HN; Bloom SR; Adrian TE; Prinz RA; Baron JH; Welbourn RB
Scand J Gastroenterol Suppl; 1980; 66():57-61. PubMed ID: 6113682
[TBL] [Abstract][Full Text] [Related]
17. Activation of the parasympathetic nervous system is necessary for normal meal-induced insulin secretion in rhesus macaques.
D'Alessio DA; Kieffer TJ; Taborsky GJ; Havel PJ
J Clin Endocrinol Metab; 2001 Mar; 86(3):1253-9. PubMed ID: 11238517
[TBL] [Abstract][Full Text] [Related]
18. Correlation of cardiovascular and neuroendocrine tests of autonomic function in diabetes.
Ewing DJ; Bellavere F; Espi F; McKibben BM; Buchanan KD; Riemersma RA; Clarke BF
Metabolism; 1986 Apr; 35(4):349-53. PubMed ID: 3959905
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal regulatory peptides during oxytocin infusion in post-term pregnancies.
Holst N; Jenssen TG; Burhol PG; Jorde R
Acta Physiol Scand; 1988 Jan; 132(1):23-7. PubMed ID: 2906209
[TBL] [Abstract][Full Text] [Related]
20. The significance of impaired pancreatic polypeptide and epinephrine responses to hypoglycemia in patients with insulin-dependent diabetes mellitus.
Kennedy FP; Bolli GB; Go VL; Cryer PE; Gerich JE
J Clin Endocrinol Metab; 1987 Mar; 64(3):602-8. PubMed ID: 3818892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
